Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Immune changes in post-menopausal osteoporosis: The Immunos study
Osteoporosis International, 11/03/09
Breuil V et al. – These results suggest that, regardless of age and estrogen status, postmenopausal OP is associated with immune changes, highlighting a possible role of IFN-&Upsilon in the pathophysiology of OP and reporting, for the first time, changes in several B lymphocyte populations. These alterations may reflect the frailty observed after fracture, providing new insight into the mechanisms of morbidity and mortality associated with OP fractures.
Methods- Analyzed surface markers of peripheral B, CD4+ and CD8+ lymphocytes and cytokine secretion in supernatants of these cells cultured with or without stimulation
- Body composition assessed by dual energy X-ray absorptiometry
- 2 groups were similar for age and estrogen level
- OP women had significantly lower BMI, fat mass, and lean mass
- Number of CD19+, CD19+/CD27+, CD19+/CD27+/CD5?/CD38+ and CD19+/CD27+/RANK+, CD4+/CD27+/CD45RA?/RANK+, and CD4+/CD27+/CD45RA?/CD28+ lower in OP women and positively correlated to BMD
- In OP women, under basal conditions, CD4+ secreted less IFN-? and B lymphocytes more granulocyte macrophage colony-stimulating factor (GM-CSF)
- GM-CSF positively correlated to fracture rate and negatively to BMD
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Sponsor
Article Search
Sponsor


See All



